Call it crowdsourcing for cures. Fed up with outdated models for finding new treatments that have missed the mark, drugmakers and other public health stakeholders have ignited open source efforts that involve networks of companies and scientists joining forces to discover drugs. And one of the pioneering efforts of this ilk in India is moving ahead with a mid-stage trial for a drug against tuberculosis.
India's Open Source Drug Discovery unit, which uses an online infrastructure to connect more than 5,500 scientists and others, revealed late last month with the Global Alliance on TB that the anti-tuberculosis molecule will be investigated in a Phase IIb trial in India, Forbes reported. And the open source group has two more TB molecules in advanced preclinical testing that could eventually enter trials and combat the infectious disease, which kills about 400,000 people annually in India.
Read more: Big Pharmas back open source drug discovery with money and molecules - FierceBiotechIT http://www.fiercebiotechit.com/story/big-pharmas-back-open-source-drug-discovery-money-and-molecules/2012-04-09?utm_medium=nl&utm_source=internal#ixzz1rZPPBBlp
Subscribe: http://www.fiercebiotechit.com/signup?sourceform=Viral-Tynt-FierceBiotechIT-FierceBiotechIT
No comments:
Post a Comment